Cispaltin And Analogues Flashcards

1
Q

What is the mechanism of action for cisplatin and its analogues

A

Formation of platinum-DNA adducts
Activate various signal transactions pathways

Involve cross-linking of 2 nucleotides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What 2 nucleotides are usually affected by cisplatin and its analogues

A

Guanine and adenine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the mechanism of action for cisplatin

A

Kill tumour cells as a direct consequence of the damage caused by their reaction w DNA
Correlated closely with covalent binding to nuclear DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What do the most active platinum compounds have in common

A

2 labels bonds to platinum atom
= can from 2 bonds w cellular target molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the metabolism of cisplatin

A

Cisplatin -> squealed platinum complex -> DNA cross links

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the rate limiting step in the reaction of platinum

A

Intracellular hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the metabolism of carboplatin

A

Carboplatin -> monofunctional adduct -> bifunctional adduct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why does carboplatin have a lower interaction with DNA compared to cisplatin

A

Due to the slow loss of the second arm of the bidentate ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the major difference bwteeen cisplatin and carboplatin

A

Kinetics of adduct formation not the nature of the reaction with DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the most common type of cisplatin adduct formation

A

Intrastrand cross links
Less than 10% interstrand and DNA-protein cross-links

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why are testicular cancer cells limes hypersensitive to cisplatin

A

Reduced DNA-repair activity in response to adducts
Low constitutive nucleotide excision repair pathway
Low DNA repair capability = cisplatin induced apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the two classes of resistance to platinum agents

A

Reduced access of drug to target DNA i.e decreased uptake into cells, changes in tumour vasculature
Increased repair or tolerance of DNA damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the mechanism of resistance to cisplatin when there is insufficient DNA binding

A

Related to decreased drug uptake by CTR1
Increased levels of cytoplasmic thiol-containing species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the mechanism of resistance to cisplatin when there is resistance mediated after DNA binding

A

Increased DNA-repair capacity
Increased tolerance to platinum-induced DNA damage through loss of MMR pathway = decreased apoptosis
Decreased expression of apoptotic signalling pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the DNA-repair pathways that is known to remove cisplatin lesions from DNA

A

Nucleotide - excision repair (NER)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can the influx and efflux of cisplatin in tumour cells be affected

A

Influx: CTR1
Efflux: ATP7a/b

17
Q

What are the different strategies used to circumvent cisplatin resistance

A

Increased delivery of platinum to the tumour
Platinum resistance modulators
Combination of platinum drugs with molecularly targeted agents
Novel platinum drugs targeting resistance mechanism

18
Q

What have in vitro studies shown to be the major cause of cisplatin resistance

A

Reduced drug uptake

19
Q

What malignancies can cisplatin be used to treat

A

Germ cell tumours
Ovarian cancers
Head and neck cancers
Bladder cancers
Childhood cancers

20
Q

What are some severe acute and long-term toxicities of cisplatin

A

Nephrotoxicity
Neurotoxicity
Ototoxicity
Nausea and vomiting

21
Q

What malignancies can carboplatin be used to treat

A

Germ cell tumours
Ovarian cancers
Childhood cancers
High dose chemotherapy regimes

22
Q

What are some of the severe acute and long-term toxicities of carboplatin

A

Haematological toxicities e.g thrombocytopenia and neutropenia
Nausea and vomiting

23
Q

What does measuring ultrafilterable platinum show

A

Non-protein bound platinum species with anti tumour and toxic properties

24
Q

What does measuring the total platinum show

A

Protein bound and ultrafilterable platinum species

25
How are platinum compounds usually administered
IV infusion with variable infusion times
26
Describe the current approaches to carboplatin dosing
Renal function based carboplatin dosing Almost all drug elimination via kidenys Rest remains protein bound
27
What is the formula used to calculate dose of carboplatin to achieve a particular exposure
Total dose = target AUC x (GFR + 25) Target AUC values commonly 5-7mg/ml.min
28
Name 4 alternative platinum complexes
Oxaliplatin Satraplatin Picoplatin BBR3464
29
Describe oxaliplatin
Superior anti-tumour effect and reduced toxicity vs cisplatin Lack of cross-resistance w other Pt agents Neurotoxicity and nausea/vomiting
30
Describe satraplatin
Oral administration Comparable activity w carboplatin/cisplatin Lack off cross resistance w cisplatin Reduced inactivation by thiol containing species No nephro/neurotoxicity
31
Describe picoplatin
First oral and IV drug Activity in carboplatin/cisplatin resistant tumours Steric hindrance to inactivation by thiol-containing species Myelosuppresion
32
Describe BBR3436
Adducts formed may be less susceptible to repair i.e persist longer than those formed by cisplatin Activity in tumours resistant to cisplatin